Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma

Journal of Pathology

Volumn 221, Issue 3, 2010, Pages 320-330

  Peter, Martine ^a   Stransky, Nicolas ^b   Couturier, Jérôme ^a   Hupé, Philippe ^a,b,c,d   Barillot, Emmanuel ^a,c,d   De Cremoux, Patricia ^a   Cottu, Paul ^a   Radvanyi, Francois ^b   Sastre Garau, Xavier ^a  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

^c INSERM U900   (France)

^d PSL RESEARCH UNIVERSITY   (France)

Author keywords

Cervical carcinoma; Genome profiling; HPV; Integration

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COPY NUMBER VARIATION; DNA INTEGRATION; DNA REPLICATION ORIGIN; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE REARRANGEMENT; GENOME; HOST; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS REPLICATION; WART VIRUS;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENES, VIRAL; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

EID: 77953501153     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2713     Document Type: Article

References (36)

1. de Cremoux P, de la Rochefordiere A, Savignoni A, Kirova Y, Alran S, Fourchotte V, et al . Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype. Int J Cancer 2009; 124: 778-782.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19. (Pubitemid 29406813)
3. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev Cancer 2002; 2: 342-350.
4. Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, et al . Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004; 78: 11451-11460.
5. Thomas JT, Laimins LA. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J Virol 1998; 72: 1131-1137.
6. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, et al . The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci U S A 2000; 97: 10002-10007.
7. Duensing S, Munger K. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 2004; 109: 157-162.
8. Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991; 65: 606-612.
9. Hopman AH, Smedts F, Dignef W, Ummelen M, Sonke G, Mravunac M, et al . Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol 2004; 202: 23-33.
10. Schwarz E, Freese U, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, et al . Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314: 111-114.
11. Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD, Howley PM. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J 2000; 19: 5762-5771.
12. von Knebel Doeberitz M, Bauknecht T, Bartsch D, zur Hausen H. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci U S A 1991; 88: 1411-1415.
13. Ferber MJ, Thorland EC, Brink AA, Rapp AK, Phillips LA, McGovern R, et al . Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 2003; 22: 7233-7242.
14. Peter M, Rosty C, Couturier J, Radvanyi F, Teshima H, Sastre- Garau X. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 2006; 25: 5985-5993.
15. Sastre-Garau X, Favre M, Couturier J, Orth G. Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours. J Gen Virol 2000; 81: 1983-1993.
16. Reuter S, Bartelmann M, Vogt M, Geisen C, Napierski I, Kahn T, et al . APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO J 1998; 17: 215-222.
17. Pett MR, Alazawi WO, Roberts I, Dowen S, Smith DI, Stanley MA, et al . Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res 2004; 64: 1359-1368. (Pubitemid 38235604)
18. Winder DM, Pett MR, Foster N, Shivji MK, Herdman MT, Stanley MA, et al . An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events. J Pathol 2007; 213: 27-34. (Pubitemid 47354563)
19. Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, et al . Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 2008; 68: 307-313. (Pubitemid 351380133)
20. Lazo PA, DiPaolo JA, Popescu NC. Amplification of the integrated viral transforming genes of human papillomavirus 18 and its 5′- flanking cellular sequence located near the myc protooncogene in HeLa cells. Cancer Res 1989; 49: 4305-4310.
21. Wagatsuma M, Hashimoto K, Matsukura T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J Virol 1990; 64: 813-821. (Pubitemid 20032698)
22. Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog 2009; 5: e1000397.
23. Kadaja M, Sumerina A, Verst T, Ojarand M, Ustav E, Ustav M. Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J 2007; 26: 2180-2191. (Pubitemid 46625800)
24. Rigaill G, Hupé P, Almeida A, La Rosa P, Meyniel JP, Decraene C, et al . ITALICS: an algorithm for normalization and DNA copy number calling for Affymetrix SNP arrays. Bioinformatics 2008; 24: 768-774. (Pubitemid 351386914)
25. Hupé P, Stransky N, Thiery JP, Radvanyi F, Barillot E. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 2004; 20: 3413-3422. (Pubitemid 40136776)
26. La Rosa P, Viara E, Hupé P, Pierron G, Liva S, Neuvial P, et al . VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics 2006; 22: 2066-2073.
27. Luft F, Klaes R, Nees M, Durst M, Heilmann V, Melsheimer P, et al . Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 2001; 92: 9-17.
28. Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, et al . Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 2007; 46: 373-384.
29. Wilting SM, Snijders PJ, Meijer GA, Ylstra B, van den Ijssel PR, Snijders AM, et al . Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 2006; 209: 220-230.
30. Kraus I, Driesch C, Vinokurova S, Hovig E, Schneider A, von Knebel Doeberitz M, et al . The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res 2008; 68: 2514-2522.
31. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, Doeberitz MK. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene 2002; 21: 419-426.
32. Jin C, Jin Y, Gisselsson D, Wennerberg J, Wah TS, Stromback B, et al . Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma. Cytogenet Genome Res 2006; 115: 99-106.
33. Shuster MI, Han L, Le Beau MM, Davis E, Sawicki M, Lese CM, et al . A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer 2000; 28: 153-163.
34. Thorland EC, Myers SL, Gostout BS, Smith DI. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 2003; 22: 1225-1237.
35. Ferber MJ, Montoya DP, Yu C, Aderca I, McGee A, Thorland EC, et al . Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 2003; 22: 3813-3820.
36. Reuter S, Delius H, Kahn T, Hofmann B, zur Hausen H, Schwarz E. Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J Virol 1991; 65: 5564-5568.